Geriatric Oncology Surgical Assessment and Functional rEcovery After Surgery (GOSAFE)
GOSAFE Study Geriatric Oncology Surgical Assessment and Functional rEcovery After Surgery An International Prospective Audit to Evaluate Postoperative Functional Outcomes and Quality of Life After Cancer Surgery in Geriatric Patients
Multicenter, international, prospective, observational study, designed to evaluate the postoperative results in terms of quality of life and functional recovery of elderly patients after major cancer surgery.
The global expected duration of the study is 3 years, during which cancer patients over 70 years old undergoing major surgery will be evaluated before and after the surgical intervention, at 30 days, 3- and 6-months follow-up. The study is non-for-profit. Given the observational nature of the study, the original treatment plan, as designed by each individual recruiting centre, will not be altered or affected by the study inclusion. Inclusion in the study does not imply any deviation from the current standard of practice, and no change is expected to the perioperative treatment at any point. Patients will be only asked to complete simple screening/assessment tests.
Aperçu de l'étude
Description détaillée
GOSAFE study is a prospective international collaborative high-quality registry aiming to gain knowledge about postoperative outcomes in older cancer patients with a particular emphasis on QoL and FR. The target is to obtain meaningful data to assist clinicians in tailoring the care, avoiding under/over-treatment, providing robust data to identify new strategies to improve functional outcomes in older cancer patients.
Recruiting centers will collect data prospectively. Recruited patients will be followed for 6 months after their surgery.
The original treatment plan, as designed by each individual recruiting centre, will not be altered or affected by the study inclusion.
Centers should ensure that they would make every possible effort to include all consecutive eligible patients during the study period and provide completeness of data entry to ensure a 'real-life' study.
Patients both gender, both gender, aged ≥70, affected by solid malignancy undergoing elective major surgical procedures with curative or palliative intent are eligible.
Inclusion in the study does not imply any deviation from the current standard of practice, and no change is expected to the perioperative treatment at any point. Patients will be only asked to complete simple screening/assessment tests.
For every eligible patient, demographic data will be collected at baseline followed by a fast preoperative functional assessment. Data regarding surgical procedures and perioperative measures will be collected. Complications will be reported and graded according to Clavien-Dindo Classification. Three- and six-month follow up data will be collected after surgery within a range of 2 weeks from the due date.
The Full Analysis Set (FAS) consists of all registered patients. The primary endpoint will be measured for all registered subjects who fulfill preoperative and postoperative EQ VAS. Demographic and baseline patient characteristics will be summarized for all patients in the FAS. Continuous-scaled variables (e.g., age) will be summarized with means, medians, standard deviations, quartiles, and minimum and maximum values. Categorical variables (e.g., sex) will be summarized using patient counts and percentages. Study endpoints and variables will be evaluated using descriptive statistics, and the key figures of the distributions will be presented in tables. Univariate analyses will allow for a first overview of potentially influential factors.
Multiple linear regression models will be performed in order to evaluate predictors of functional recovery at 3 months and 6 months after surgery.
Exploratory subgroup analyses will be performed. Missing values will be replaced and estimated using multiple imputations. Furthermore, sensitivity analysis will be executed using complete-case analysis.
A sample size of 265 patients who completed pre and postoperative EQ VAS questionnaires will have a 90% power to detect an effect size of 0,2 between pre and post surgery ,using a paired t-test with a 0,05 two sided significance level.
Given a potential loss to follow-up (about 10%), uncompleted questionnaires (about 10%) and postoperative mortality (about 15%), the sample size will be increased to 350-400 patients (see ref 18 and 19).
Type d'étude
Inscription (Réel)
Contacts et emplacements
Lieux d'étude
-
-
-
Alicante, Espagne, 03001
- Universidad Miguel Hernández. Elche. Alicante
-
Valencia, Espagne, 46700
- Hospital Universitario y Politécnico La Fe
-
-
-
-
-
Thessaloníki, Grèce, 54248
- Medical School, Aristotle University of Thessaloniki
-
-
-
-
-
Petah Tikva, Israël, 4592500
- Rabin Medical Center
-
-
-
-
-
Milano, Italie, 20162
- Ospedale Niguarda
-
Piacenza, Italie, 29121
- Ospedale di Piacenza
-
Vercelli, Italie, 13100
- Clinica S. Rita
-
-
Forli-Cesena
-
Forlì, Forli-Cesena, Italie, 47121
- Ospedale di Forlì
-
-
Lazio
-
Roma, Lazio, Italie, 00100
- Ospedale S. Andrea
-
-
Liguria
-
Genova, Liguria, Italie, 16121
- IRCCS Ospedale S. Martino Genova, Chirurgia Generale ad indirizzo oncologico
-
Genova, Liguria, Italie, 16121
- IRCCS Ospedale S. Martino Genova, Clinica Chirurgica 1
-
-
Milano
-
Rozzano, Milano, Italie, 20089
- Humanitas
-
-
Monza E Brianza
-
Desio, Monza E Brianza, Italie, 20039
- Ospedale di Desio
-
-
Perugia
-
Spoleto, Perugia, Italie, 06049
- Ospedale S. Matteo degli Infermi
-
-
Puglia
-
Bari, Puglia, Italie, 70121
- IstitutoTumori Giovanni Paolo II
-
-
Ravenna
-
Faenza, Ravenna, Italie, 48018
- General Surgery Unit
-
-
Rimini
-
Riccione, Rimini, Italie, 47838
- Ospedale di Riccione
-
-
-
-
-
Lisbon, Le Portugal
- General Surgery dept,Hospital Sao Francisco Xavier (CHLO)
-
Santiago do Cacém, Le Portugal, 7500
- Unidade Local de Saúde do Litoral Alentejano (ULSLA)
-
-
-
-
-
Oslo, Norvège
- Institute of Clinical Medicine
-
-
-
-
-
Groningen, Pays-Bas
- Groeningen University Hospital
-
-
-
-
-
Kraków, Pologne
- Jagiellonian University Medical College
-
-
-
-
-
Liverpool, Royaume-Uni
- Dept. of Surgical Oncology - St. Helens Hospital of Liverpool
-
Manchester, Royaume-Uni
- Manchester Royal Infirmary, University of Manchester
-
-
-
-
Florida
-
Weston, Florida, États-Unis, 33331
- Cleveland Clinic Florida
-
-
Massachusetts
-
Boston, Massachusetts, États-Unis, 02115
- Brigham and Women's Hospital
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, États-Unis, 19104
- University of Pennsylvenia Medical Center
-
-
Rhode Island
-
Providence, Rhode Island, États-Unis, 02908
- Roger William Medical Centre
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
La description
Inclusion Criteria:
- All consecutive patients, both gender, aged ≥70
- Patients affected by solid malignancy
- Patients undergoing elective major surgical procedures with curative or palliative intent (all major procedures including any resection, for any cancer, via any operative approach, open, laparoscopic, robotic, etc…)
- Informed consent obtainment
Exclusion Criteria:
- Patients undergoing emergent/urgent surgical procedures
- Planned hospital stay less than 48 hours
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Cohortes et interventions
Groupe / Cohorte |
Intervention / Traitement |
|---|---|
|
Group 1
Elderly patiences with solid malignancy
|
Quality of Life and Functional recovery questionnaires
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Quality of Life (QoL)
Délai: 6 months
|
To evaluate the effects of surgery on patients' life perception by comparing pre- and post-operative QoL in elderly patients undergoing major surgery for solid malignancies using a self-reported Quality of Life assessment tool
|
6 months
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Functional recovery (FR)
Délai: 6 months
|
To evaluate FR in terms of nutritional status, restoration of daily activities and cognitive status
|
6 months
|
|
Morbidity
Délai: 6 months
|
To evaluate 3 and 6 months postoperative morbidity
|
6 months
|
|
Mortality
Délai: 6 months
|
To evaluate 3 and 6 months postoperative mortality
|
6 months
|
|
Prognostic factors
Délai: 6 months
|
To obtain prognostic factors for postoperative functional recovery which will assist in the treatment planning /intervention of future elderly patients who are offered surgery for cancer
|
6 months
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Les enquêteurs
- Chercheur principal: Giampaolo Giampaolo, MD, AUSL Romagna
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Anticipé)
Achèvement de l'étude (Anticipé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- GOSAFE
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .